Immunocore Holdings plc
IMCR
$28.01
-$0.51-1.79%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 143.15% | -16,883.05% | 98.28% | -305.06% | 121.13% |
| Total Depreciation and Amortization | 13.67% | 4.51% | 2.31% | -8.67% | -26.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.72% | 730.78% | -142.90% | 303.51% | -83.42% |
| Change in Net Operating Assets | -10.29% | -1,946.98% | -104.95% | 451.33% | -71.98% |
| Cash from Operations | 57.82% | -632.83% | -117.16% | 5,868.74% | 103.12% |
| Capital Expenditure | 38.16% | -285.03% | -80.68% | -38.93% | 91.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 200.00% | -66.67% | 120.00% | -400.00% | -- |
| Cash from Investing | 579.43% | -116.76% | 117.27% | -413.48% | 374.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -84.69% | 129.58% | -49.16% | 43.87% | 363.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -84.69% | 129.58% | -49.16% | 43.87% | 104.95% |
| Foreign Exchange rate Adjustments | -322.16% | -118.59% | -34.13% | 40.85% | 164.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.04% | -392.98% | -5.48% | -47.49% | 125.74% |